Functional magnetic resonance imaging in coronavirus disease 2019 induced olfactory dysfunction

J Laryngol Otol. 2024 Feb;138(2):178-183. doi: 10.1017/S0022215123001652. Epub 2023 Oct 5.

Abstract

Objective: To evaluate the functional magnetic resonance imaging changes in the olfactory structures of coronavirus disease 2019 patients experiencing olfactory dysfunction.

Methods: This study included patients aged 25-65 years who presented with a sudden loss of smell, confirmed coronavirus disease 2019 infection, and persistent olfactory dysfunction for a minimum of 2 months without any treatment.

Results: Irrespective of the side of brain activation, the analysis of the cumulative maximum diameter of the activation zones revealed significantly lower activation in the upper frontal lobe (p = 0.037) and basal ganglia (p = 0.023) in olfactory dysfunction patients. Irrespective of the side of activation, the analysis of the number of activation points demonstrated significantly lower activation in the upper frontal lobe (p = 0.036) and basal ganglia (p = 0.009) in olfactory dysfunction patients.

Conclusion: Patients with coronavirus-triggered olfactory dysfunction exhibited lower activity in their basal ganglia and upper frontal lobe.

Keywords: Coronavirus; diagnostic imaging; magnetic resonance imaging; quality of life; smell.

MeSH terms

  • Brain / diagnostic imaging
  • Brain / pathology
  • COVID-19* / complications
  • COVID-19* / diagnostic imaging
  • COVID-19* / pathology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Olfaction Disorders* / diagnostic imaging
  • Olfaction Disorders* / etiology
  • Olfaction Disorders* / pathology
  • Smell / physiology